A new technology developed by Quadridox, a company nestled in an old textile manufacturing building near the Eno River, is poised to revolutionize both airline security and healthcare diagnostics. Unlike traditional X-rays used in medical settings, Quadridox’s X-ray diffraction imaging analyzes materials by observing how X-rays interact with atoms, offering a level of specificity that can differentiate between harmless substances and potential threats.
Joel Greenberg, the co-founder and CEO of Quadridox, envisions a future where airport security processes are expedited and enhanced accuracy leads to fewer delays. This technology has the potential to allow passengers to carry previously restricted items like water bottles through TSA checkpoints, thanks to its capability to distinguish between safe liquids and hazardous substances.
While X-ray diffraction has been around for a century primarily for laboratory purposes, Quadridox’s innovative application of the technology for broader use stems from Greenberg’s time as a researcher at Duke University. Supported by Duke’s Office for Translation & Commercialization, Quadridox was founded in 2018 and has since expanded to a team of 15 employees, drawing talent from various North Carolina universities.
David Coccarelli, a fellow Duke graduate and Quadridox’s co-founder and COO, emphasizes the importance of the technology’s readiness for real-world deployment. The company’s growth and success have been bolstered by Duke’s backing and continuous federal funding, essential for advancing their product development.
Quadridox’s headquarters houses a testing facility with full-scale prototypes and a conveyor belt system for evaluating the technology’s effectiveness in scanning diverse items. Greenberg anticipates deploying test machines in Eastern U.S. airports within the next year, with rigorous regulatory approval processes set by the TSA.
Beyond airport security, Quadridox is also developing a portable version of its X-ray diffraction imaging technology for healthcare settings. Intended to complement existing diagnostic tools like MRI and ultrasound, this innovation aims to provide quicker and more accurate tissue evaluations, potentially aiding in distinguishing between benign and malignant conditions.
The team at Quadridox envisions their technology making a tangible impact in the real world, whether through enhancing airport security measures or improving healthcare diagnostics. Their dream is to witness the widespread adoption of their technology, knowing it has the potential to save lives and streamline critical processes.
📰 Related Articles
- Thailand’s Online Betting Regulations Set to Transform Gambling Landscape
- Off-Road Motorcycle Market Set to Double by 2031 Amid Innovation and Growth
- Giant Robotic Centipedes Transform Agriculture with Bioinspired Innovation
- Dubai Airport Implements Stricter Security Measures for Travelers
- ofi Unveils Sustainable Coffee Facility in Brazil, Driving Innovation